The High Cost of Slow Decision Making in Pharma
Slow decisions cost more than mistakes. In pharma, they cost time, money, and sometimes patient access. Every delay whether it’s waiting for a supplier approval, signing off a forecast, or finalizing a production change carries a price tag that few notice until it’s too late. Many companies assume that being careful means being slow. But […]